BAY-43-9695
Code | Size | Price |
---|
TAR-T67788-1mg | 1mg | £239.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T67788-5mg | 5mg | £496.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T67788-1mL | 1 mL * 10 mM (in DMSO) | £550.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T67788-10mg | 10mg | £713.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T67788-25mg | 25mg | £1,316.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T67788-50mg | 50mg | £1,789.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
BAY-43-9695 is a non-nucleoside compound with anti-human cytomegalovirus (HCMV) activity. It is the major metabolite of BAY-38-4766.
CAS:
233255-39-5
Formula:
C22H25N3O4S
Molecular Weight:
427.52
Pathway:
Microbiology/Virology|Proteases/Proteasome
Purity:
0.9951
SMILES:
O=C(NC1=CC=C(C=C1)NS(=O)(=O)C=2C=CC=C3C(=CC=CC32)NC)C(C)(C)CO
Target:
HCV Protease
References
Keywan K, et al. The antiviral activity exerted by vaccinia virus on the growth of herpes simplex virus in BS-C-1 cells. Antiviral Res. 2000;46(2):145-155.
McSharry JJ, et al. Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir. Antimicrob Agents Chemother. 2001;45(10):2925-2927.